发明名称 |
STABILISED FIBRATE MICROPARTICLES |
摘要 |
This invention discloses an orally administered pharmaceutical composition comprising microparticles of solid fenofibrate that are stabilized by a phospholipid surface active substance that is present during the preparation of the microparticles, wherein a therapeutically effective amount of the composition provides a quantity of fenofibrate active species to a fasted human patient in need of treatment by fenofibrate that is greater than 80 % of the quantity of fenofibrate active species provided by the same amount of the composition when administered to the same patient who has been fed a high fat meal consisting of at least 1000 calories, 50 % of which are from fat. The present invention also provides a method of treatment of dislipidemia and dislipoproteinemia in a mammal consisting of administering a therapeutically effective oral dosage form comprising microparticles of a solid fibrate that are stabilized by a phospholipid surface active substance wherein the dosage form provides into the blood of the patient in a fasted state a therapeutically effective amount of a fibrate active species that is at least 90 % of the AUC amount of the fibrate active species provided by the same dosage form into the blood of the same patient when the patient is in a fed state.
|
申请公布号 |
WO0224193(A1) |
申请公布日期 |
2002.03.28 |
申请号 |
WO2001US12826 |
申请日期 |
2001.04.20 |
申请人 |
RTP PHARMA INC. |
发明人 |
GUIVARC'H, POL-HENRI;PACE, GARY;SNOW, ROBERT, A. |
分类号 |
A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K31/216;A61K31/22;A61K31/365;A61K31/40;A61K31/405;A61K31/44;A61K31/505;A61K31/66;A61K47/10;A61K47/24;A61K47/26;A61P3/06;(IPC1-7):A61K31/216 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|